Abstract

Reproducible and standardised neurological assessment scales are important in quantifying research outcomes. These scales are often performed by non-neurologists and/or non-clinicians and must be robust, quantifiable, reproducible and comparable to a neurologist's assessment. COVID-CNS is a multi-centre study which utilised the Neurological Impairment Scale (NIS) as a core assessment tool in studying neurological outcomes following COVID-19 infection. We investigated the strengths and weaknesses of the NIS when used by non-neurology clinicians and non-clinicians, and compared performance to a structured neurological examination performed by a neurology clinician. Through our findings, we provide practical advice on how non-clinicians can be readily trained in conducting reproducible and standardised neurological assessments in a multi-centre study, as well as illustrating potential pitfalls of these tools.

Original languageEnglish
Article number100241
JournalClinical Medicine, Journal of the Royal College of Physicians of London
Volume24
Issue number5
DOIs
Publication statusPublished - Sept 2024

Keywords

  • Clinical study
  • COVID-19
  • Neurological assessment
  • Neurology
  • Outcome tool

Fingerprint

Dive into the research topics of 'Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study'. Together they form a unique fingerprint.

Cite this